Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril effects on CSF Beta-Amyloid in Alzheimer's risk
NCT00980785Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Apr 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramipril in Alzheimer's disease (AD), sponsored by University of Wisconsin–Madison. Started Apr 2009; status: completed.
02
Drugs
ramipril
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00980785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980785.